Scher pointed out that no drug with a OS benefit in PCa has a pain benefit on its label. This includes cabazitaxel and docetaxel.
Unless otherwise indicated, this is the personal viewpoint of David Miller and not necessarily that of Biotech Stock Research, LLC. We're on Twitter at BiotechStockRsr